Tempest Therapeutics' Series A Round

Tempest Therapeutics raised a round of funding on November 24, 2011. Investors include Versant Ventures.

Tempest Therapeutics, fka Inception 2 and fka Next Beta, is a development stage biotechnology company that is focused on small molecule therapeutics that modulate anti-tumor immunity pathways.…

Articles about Tempest Therapeutics' Series A Round: